Houston recognized among the best hospital cities in the nation

just what the doctor ordered

Houston, home to the largest medical center in the world, was ranked among the best cities for health care in the country. Photo by Dwight C. Andrews/Greater Houston Convention and Visitors Bureau

As home to Texas Medical Center — the world's largest medical complex — it stands to reason that Houston ranks among the country's best cities for health care. A new study bolsters that notion, but it also points out that several health care measures in Houston need some TLC.

The study, conducted by digital health care provider Medbelle, ranks Houston as the ninth best "hospital city" in the United States. Medbelle sifted through data in three categories (health care infrastructure, quality of health care and access to health care) to develop the ranking. Within those categories, Medbelle examined factors like quality of medical education, number of hospital beds, shortage of nurses, efficiency of cancer treatment, and prevalence of mental health specialists.

"Houston is known internationally as the home of one of the best medical communities in the world," the City of Houston declares.

In the Medbelle study, Boston landed at No. 1 in the U.S.; Tokyo took the global crown. At No. 13, Dallas was the only other Texas city to earn a place on the U.S. list.

Medbelle says it compiled the ranking to highlight regional hospital "ecosystems" rather than specific hospitals. The Houston area has more than 85 hospitals.

Houston's hospital ecosystem scored 94.92 out of 100, yet sits in next-to-last place for access to health care (48.83 out of 100), Medbelle notes. Daniel Kolb, co-founder and managing director of Medbelle, says this means that while Houston enjoys one of the best medical infrastructures in the world, a relatively small percentage of people in the region can take advantage of it.

In 2018, nearly 1 in 5 residents of the Houston area (18.6 percent) lacked health insurance, the U.S. Census Bureau says. That's the highest rate of uninsured residents among the country's 25 most populous metro areas. Affordability and availability continue to exacerbate the health insurance predicament in Houston and around the country.

"The single biggest issue in health care for most Americans is that their health costs are growing much faster than their wages are," Drew Altman, president of the Kaiser Family Foundation, says in a release. "Costs are prohibitive when workers making $25,000 a year have to shell out $7,000 a year just for their share of family premiums."

For those who can afford medical care, the Houston area boasts some of the best hospitals in the U.S. MD Anderson Cancer Center reigns as the country's top cancer hospital, for instance.

In May, The Leapfrog Group, a nonprofit representing large employers in the U.S., assigned its highest grade — "A" — to these nine hospitals in the Houston area:

  • HCA Houston Healthcare (Kingwood)
  • Houston Methodist Hospital
  • Houston Methodist Sugar Land Hospital
  • Houston Methodist West Hospital
  • Houston Methodist Willowbrook Hospital
  • Memorial Hermann Memorial City Medical Center
  • Memorial Hermann The Woodlands Hospital
  • Tomball Regional Medical Center
  • West Houston Medical Center

From another perspective, U.S. News & World Report ranks Houston Methodist Hospital as the best hospital in the Houston area, followed by Baylor St. Luke's Medical Center, Memorial Hermann Greater Heights Hospital, Memorial Hermann-Texas Medical Center, and Houston Methodist Sugar Land Hospital.

Meanwhile, Houston-area physicians hold Texas Children's Hospital West Campus in the highest regard among the region's hospitals, trailed by Houston Methodist West Hospital, MD Anderson Cancer Center, Texas Children's Hospital, and Children's Memorial Hermann Hospital.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”